Josh Rosaasen is the Chief Operating Officer at Locke Bio, a digital health platform revolutionizing how branded telehealth services are launched. He has been a driving force behind the company’s rapid growth, expanding its client base, diversifying revenue streams, and enhancing its market-leading platform. Before joining Locke Bio, he led high-impact strategic initiatives within the cannabis industry and advised multibillion-dollar retail clients as a management consultant. A lifelong advocate for healthcare innovation, he has also contributed to published research and spearheaded leadership initiatives with the Canadian Cancer Society.
The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, regulators, and platforms — must collaborate to sustain that trust.